Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI

    Multiparametric MRI is the optimal primary investigation when prostate cancer is suspected, and its ability to rule in and rule out clinically significant disease relies on high-quality anatomical and function...

    Maarten de Rooij, Clare Allen, Jasper J. Twilt, Linda C. P. Thijssen in European Radiology (2024)

  2. Article

    Open Access

    ESR Essentials: using the right scoring system in prostate MRI—practice recommendations by ESUR

    MRI has gained prominence in the diagnostic workup of prostate cancer (PCa) patients, with the Prostate Imaging Reporting and Data System (PI-RADS) being widely used for cancer detection. Beyond PI-RADS, other...

    Andrea Ponsiglione, Giorgio Brembilla, Renato Cuocolo in European Radiology (2024)

  3. No Access

    Article

    Improving image quality in prostate MRI: the time is now

    Giorgio Brembilla, Francesco Giganti in European Radiology (2024)

  4. Article

    Active surveillance of prostate cancer: MRI and beyond

    Rossano Girometti, Francesco Giganti in European Radiology (2024)

  5. Article

    Open Access

    Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship

    The Prostate Imaging Quality (PI-QUAL) score is a new metric to evaluate the diagnostic quality of multiparametric magnetic resonance imaging (MRI) of the prostate. This study assesses the impact of an interve...

    Francesco Giganti, Alexander P. Cole, Fiona M. Fennessy in European Radiology (2023)

  6. Article

    Open Access

    Promoting the use of the PRECISE score for prostate MRI during active surveillance: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship

    The PRECISE criteria for serial multiparametric magnetic resonance imaging (MRI) of the prostate during active surveillance recommend the use of a dedicated scoring system (PRECISE score) to assess the likelih...

    Francesco Giganti, Laurene Aupin, Camille Thoumin, Ingrid Faouzi in Insights into Imaging (2022)

  7. Article

    Open Access

    Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial

    The Prostate Imaging Quality (PI-QUAL) score assesses the quality of multiparametric MRI (mpMRI). A score of 1 means all sequences are below the minimum standard of diagnostic quality, 3 implies that the scan ...

    Francesco Giganti, Eoin Dinneen, Veeru Kasivisvanathan, Aiman Haider in European Radiology (2022)

  8. Article

    Open Access

    Multiparametric prostate MRI quality assessment using a semi-automated PI-QUAL software program

    The technical requirements for the acquisition of multiparametric magnetic resonance imaging (mpMRI) of the prostate have been clearly outlined in the Prostate Imaging Reporting and Data System (PI-RADS) guide...

    Francesco Giganti, Sydney Lindner, Jonathan W. Piper in European Radiology Experimental (2021)

  9. Article

    Open Access

    Understanding PI-QUAL for prostate MRI quality: a practical primer for radiologists

    Prostate magnetic resonance imaging (MRI) of high diagnostic quality is a key determinant for either detection or exclusion of prostate cancer. Adequate high spatial resolution on T2-weighted imaging, good dif...

    Francesco Giganti, Alex Kirkham, Veeru Kasivisvanathan in Insights into Imaging (2021)

  10. Article

    Open Access

    Standardisation of prostate multiparametric MRI across a hospital network: a London experience

    National guidelines recommend prostate multiparametric (mp) MRI in men with suspected prostate cancer before biopsy. In this study, we explore prostate mpMRI protocols across 14 London hospitals and determine ...

    Marianthi-Vasiliki Papoutsaki, Clare Allen, Francesco Giganti in Insights into Imaging (2021)

  11. Article

    Open Access

    Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort

    The PRECISE recommendations for magnetic resonance imaging (MRI) in patients on active surveillance (AS) for prostate cancer (PCa) include repeated measurement of each lesion, and attribution of a PRECISE radi...

    Francesco Giganti, Armando Stabile, Vasilis Stavrinides in European Radiology (2021)

  12. Article

    Open Access

    ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists’ training

    This study aims to define consensus-based criteria for acquiring and reporting prostate MRI and establishing prerequisites for image quality.

    Maarten de Rooij, Bas Israël, Marcia Tummers, Hashim U. Ahmed in European Radiology (2020)

  13. Article

    Open Access

    Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study

    We aimed to determine the interobserver reproducibility of the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) criteria for magnetic resonance imaging in patients on active...

    Francesco Giganti, Martina Pecoraro, Vasilis Stavrinides in European Radiology (2020)

  14. Article

    Correction to: Machine learning classifiers can predict Gleason pattern 4 prostate cancer with greater accuracy than experienced radiologists

    The original version of this article, published on 11 June 2019, unfortunately contained a mistake. The following correction has therefore been made in the original: In section “Multiparametric MRI review,” th...

    Michela Antonelli, Edward W. Johnston, Nikolaos Dikaios in European Radiology (2020)

  15. Article

    Open Access

    Gastric cancer and image-derived quantitative parameters: Part 2—a critical review of DCE-MRI and 18F-FDG PET/CT findings

    There is yet no consensus on the application of functional imaging and qualitative image interpretation in the management of gastric cancer. In this second part, we will discuss the role of image-derived quant...

    Lei Tang, Xue-Juan Wang, Hideo Baba, Francesco Giganti in European Radiology (2020)

  16. Article

    Open Access

    Machine learning classifiers can predict Gleason pattern 4 prostate cancer with greater accuracy than experienced radiologists

    The purpose of this study was: To test whether machine learning classifiers for transition zone (TZ) and peripheral zone (PZ) can correctly classify prostate tumors into those with/without a Gleason 4 componen...

    Michela Antonelli, Edward W. Johnston, Nikolaos Dikaios in European Radiology (2019)

  17. Article

    Open Access

    Multi-parametric MRI zone-specific diagnostic model performance compared with experienced radiologists for detection of prostate cancer

    Compare the performance of zone-specific multi-parametric-MRI (mp-MRI) diagnostic models in prostate cancer detection with experienced radiologists.

    Nikolaos Dikaios, Francesco Giganti, Harbir S. Sidhu in European Radiology (2019)

  18. Article

    Open Access

    Gastric cancer and imaging biomarkers: Part 1 – a critical review of DW-MRI and CE-MDCT findings

    The current standard of care for gastric cancer imaging includes heterogeneity in image acquisition techniques and qualitative image interpretation. In addition to qualitative assessment, several imaging techn...

    Francesco Giganti, Lei Tang, Hideo Baba in European Radiology (2019)

  19. Article

    Open Access

    An update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines

    The aim of the current report is to provide an update in the imaging interpretation of prostate cancer on multiparametric magnetic resonance imaging (mpMRI), with a special focus on how to discriminate patholo...

    Valeria Panebianco, Francesco Giganti, Yu Xuan Kitzing in Insights into Imaging (2018)

  20. Article

    Open Access

    MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial

    To investigate changes in the Apparent Diffusion Coefficient (ADC) using diffusion-weighted imaging (DWI) in men on active surveillance for prostate cancer taking dutasteride 0.5 mg or placebo.

    Francesco Giganti, Caroline M. Moore, Nicola L. Robertson in European Radiology (2017)

previous disabled Page of 2